Dr. John Chatas

Dr. Brummett is a Professor at the University of Michigan where he serves as the Senior Associate Chair for Research. He has more than 200 publications, including articles in top journals such as JAMA, JAMA Surgery, Anesthesiology, and Annals of Surgery. He is the Co-Director of the Opioid Prescribing Engagement Network (OPEN) at the University of Michigan, which aims to apply a preventative approach to the opioid epidemic in the US through appropriate prescribing after surgery, dentistry, and emergency medicine. In addition, his research interests include predictors of acute and chronic post-surgical pain and failure to derive benefit for interventions for interventions and surgeries primarily performed to treat pain. Dr. Brummett is interested in the impact of a fibromyalgia-like or centralized pain phenotype on analgesic outcomes. He is the Co-PI of multiple NIH grants studying these concepts and receives funding from the Michigan Department of Health and Human Services, SAMHSA, CDC, and multiple foundations. Dr. Brummett is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Fibromyalgia, Chronic Pain, Acute Pain, Shoulder Arthroscopy, and Hip Replacement. Dr. Brummett is board certified in Anesthesiology and Pain Medicine.

Srinivas Chiravuri is a Pain Medicine specialist and an Anesthesiologist practicing medicine in Ann Arbor, Michigan. Dr. Chiravuri is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Acute Pain, Pudendal Neuralgia, Wallerian Degeneration, and Giant Axonal Neuropathy.

Mark C. Bicket, MD, PhD is an Associate Professor in the Departments of Anesthesiology and Health Management & Policy at the University of Michigan, where he directs pain and opioid research. He co-directs the Overdose Prevention Engagement Network (OPEN), an initiative to prevent, treat, and reduce harms from substance use through community partnerships and stigma reduction. His research integrates clinical trials, health policy analyses, and pharmacoepidemiology.Dr. Bicket has pioneered evidence-based approaches to reduce opioid-related harms and advanced the treatment of pain. He leads two NIH R01s to improve care for persons with opioid use disorder who have surgery and leads two pragmatic clinical trials funded by the Patient-Centered Outcomes Research Institute including CARES for Kids, which compares commonly prescribed treatments for postoperative pain among adolescents and young adults.Previously, he directed the nationally recognized pain medicine fellowship program and quality and safety for pain at Johns Hopkins, where he led creation of their first system-wide pain management policy. Dr. Bicket votes as a member of the FDA committee on analgesics and has advised CMS, state governments, and national organizations on pain and opioid issues. His research, which includes 130 peer-reviewed articles, has appeared in JAMA, NEJM, and BMJ and has support from the Foundation for Anesthesia Education and Research (FAER), SAMHSA, and CDC. Dr. Bicket’s leadership has led to national recognition including the 2024 Presidential Scholar Award from the American Society of Regional Anesthesia, the White House Fellowship, and election as a Fellow of the American Society of Anesthesiologists. Dr. Bicket is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Acute Pain, Chronic Pain, Fibromyalgia, Gallbladder Removal, and Knee Replacement. Dr. Bicket is board certified in Anesthesiology and Pain Medicine.